HomeCompareBHCCF vs JNJ

BHCCF vs JNJ: Dividend Comparison 2026

BHCCF yields 546.75% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BHCCF wins by $123396.35M in total portfolio value
10 years
BHCCF
BHCCF
● Live price
546.75%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$123396.37M
Annual income
$90,746,503,788.55
Full BHCCF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BHCCF vs JNJ

📍 BHCCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBHCCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BHCCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BHCCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BHCCF
Annual income on $10K today (after 15% tax)
$46,473.48/yr
After 10yr DRIP, annual income (after tax)
$77,134,528,220.27/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BHCCF beats the other by $77,134,527,516.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BHCCF + JNJ for your $10,000?

BHCCF: 50%JNJ: 50%
100% JNJ50/50100% BHCCF
Portfolio after 10yr
$61698.19M
Annual income
$45,373,252,308.16/yr
Blended yield
73.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BHCCF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.9
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BHCCF buys
0
JNJ buys
0
No recent congressional trades found for BHCCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBHCCFJNJ
Forward yield546.75%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$123396.37M$20.0K
Annual income after 10y$90,746,503,788.55$827.78
Total dividends collected$120616.07M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: BHCCF vs JNJ ($10,000, DRIP)

YearBHCCF PortfolioBHCCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$65,375$54,674.69$10,676$355.77+$54.7KBHCCF
2$404,001$334,050.50$11,407$389.39+$392.6KBHCCF
3$2,361,590$1,929,308.28$12,198$426.53+$2.35MBHCCF
4$13,066,872$10,539,971.20$13,056$467.62+$13.05MBHCCF
5$68,484,857$54,503,303.99$13,987$513.12+$68.47MBHCCF
6$340,248,490$266,969,692.64$14,998$563.56+$340.23MBHCCF
7$1,603,660,939$1,239,595,054.50$16,098$619.52+$1603.64MBHCCF
8$7,176,165,623$5,460,248,418.25$17,295$681.69+$7176.15MBHCCF
9$30,513,892,122$22,835,394,906.01$18,599$750.82+$30513.87MBHCCF
10$123,396,368,359$90,746,503,788.55$20,022$827.78+$123396.35MBHCCF

BHCCF vs JNJ: Complete Analysis 2026

BHCCFStock

Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass/bream, salmon, shrimp, and tilapia breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and CleanTreat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was founded in 2000 and is headquartered in Sheffield, the United Kingdom.

Full BHCCF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BHCCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BHCCF vs SCHDBHCCF vs JEPIBHCCF vs OBHCCF vs KOBHCCF vs MAINBHCCF vs ABBVBHCCF vs MRKBHCCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.